Global C-Reactive Protein Testing Market Size and Forecast 2023-2032|Thermo Fisher Scientific Inc., F Hoffmann-La Roche AG, Danaher Corporation, Quest Diagnostics Incorporated, Siemens AG

The C-Reactive Protein Testing Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The C-Reactive Protein Testing Market:

https://www.thebusinessresearchcompany.com/report/c-reactive-protein-testing-global-market-report

According to The Business Research Company’s C-Reactive Protein Testing Global Market Report 2024, The c-reactive protein testing market size has grown steadily in recent years. It will grow from $3.43 billion in 2023 to $3.55 billion in 2024 at a compound annual growth rate (CAGR) of 3.6%. The growth in the historic period can be attributed to increased inflammatory disease prevalence, cardiovascular risk assessment, increased aging population, increased healthcare infrastructure, and healthcare screening programs.

The c-reactive protein testing market size is expected to see steady growth in the next few years. It will grow to $4.16 billion in 2028 at a compound annual growth rate (CAGR) of 4.1%. The growth in the forecast period can be attributed to rising obesity rates, personalized medicine and biomarkers, telehealth and remote monitoring, early disease detection, and lifestyle-related inflammation

Major trends in the forecast period include diagnostic testing advancements, wearable health technology, technological solutions, strategic collaborations, and industry 4.0 introduction.

The increase in cases of cardiovascular diseases (CVD) are expected to propel the growth of the c-reactive protein testing market. Cardiovascular diseases refer to heart conditions such as diseased vessels, structural problems, and blood clots. The exact cause of CVD is uncertain, but numerous factors can increase the risk of developing it. One such factor is the behavioral risk caused due to unbalanced eating, lack of physical activity, smoking, and alcohol use, which results in an accumulation of fatty deposits inside the arteries (atherosclerosis), resulting in an increased risk of blood clots. These behavioral risks result in elevated blood pressure, glucose, blood lipids, weight gain, and obesity. The increasing cases of cardiovascular diseases invites the need for c-reactive protein testing to diagnose or predict the chance of having cardiovascular problems at least as well as cholesterol levels. For instance, according to the key facts published in June 2021 by the WHO (World Health Organization), cardiovascular diseases are the leading cause of death worldwide. Around 17.9 million die every year due to CVD, accounting for 32% of all global deaths. Therefore, the increasing cases of cardiovascular diseases will drive the c-reactive protein testing market growth.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=6719&type=smp

The c-reactive protein testing market covered in this report is segmented –

1) By Assay Type: Enzyme-Linked Immunosorbent Assay (ELISA), Chemiluminescence Immunoassay (CLIA), Immunoturbidimetric Assays

2) By Application: Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, Cancer, Other Applications

3) By End Use: Clinics, Hospitals, Diagnostic Laboratories

Technological advancement in measuring devices is a key trend in the c-reactive protein testing market. Major companies operating in the c-reactive protein testing market are focused on providing technologically advanced solutions to strengthen their market position. These companies are implementing next-generation c-reactive testing technologies into their testing methods and advanced solutions that provide benefits such as maximum output and multiple usages. For instance, in February 2022, Aidian, a Finnish-based diagnostic tests, and test solutions company, released the QuikRead go wrCRP & wrCRP+Hb kits. The kit consistently produces two results, a wide range of CRP and Hb, from a single sample with one analysis. The wide-range CRP test permits CRP readings to assess conditions such as neonatal sepsis, predict disease severity in COPD (chronic obstructive pulmonary disease), and assist in cardiovascular risk assessment.

The c-reactive protein testing market report table of contents includes:

1. Executive Summary

2. C-Reactive Protein Testing Market Characteristics

3. C-Reactive Protein Testing Market Trends And Strategies

4. C-Reactive Protein Testing Market – Macro Economic Scenario

5. Global C-Reactive Protein Testing Market Size and Growth

26. South America C-Reactive Protein Testing Market

27. Brazil C-Reactive Protein Testing Market

28. Middle East C-Reactive Protein Testing Market

29. Africa C-Reactive Protein Testing Market

30. C-Reactive Protein Testing Market Competitive Landscape And Company Profiles

Top Major Players: